GEODE CAPITAL MANAGEMENT, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 77 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$650,000
-24.9%
203,930
+0.5%
0.00%
Q1 2022$866,000
-34.3%
202,816
-28.6%
0.00%
Q4 2021$1,319,000
+20.1%
283,870
+3.1%
0.00%
Q3 2021$1,098,000
-6.5%
275,416
+0.4%
0.00%
Q2 2021$1,174,000
-33.5%
274,361
-34.1%
0.00%
Q1 2021$1,766,000
+13.4%
416,587
+3.7%
0.00%
Q4 2020$1,558,000
-1.5%
401,589
+2.2%
0.00%
Q3 2020$1,582,000
-6.4%
392,763
-1.0%
0.00%
Q2 2020$1,690,000
+27.6%
396,864
+25.9%
0.00%
Q1 2020$1,324,000
-51.9%
315,278
-55.0%
0.00%
Q4 2019$2,752,000
-8.4%
700,522
+105.0%
0.00%
-100.0%
Q3 2019$3,006,000
+2.7%
341,680
+8.0%
0.00%0.0%
Q2 2019$2,926,000
+74.9%
316,421
+21.6%
0.00%
Q1 2019$1,673,000
-61.0%
260,273
-42.8%
0.00%
-100.0%
Q4 2018$4,290,000
-3.2%
454,968
+106.7%
0.00%0.0%
Q3 2018$4,430,000
-25.8%
220,114
+7.6%
0.00%
-50.0%
Q2 2018$5,969,000
+17.3%
204,657
+19.8%
0.00%0.0%
Q1 2018$5,087,000
+1.4%
170,842
+9.5%
0.00%0.0%
Q4 2017$5,018,000
-3.5%
155,954
+4.3%
0.00%0.0%
Q3 2017$5,202,000
+24.5%
149,579
+6.6%
0.00%0.0%
Q2 2017$4,178,000
+27.3%
140,362
+27.7%
0.00%
+100.0%
Q1 2017$3,281,000
+77.7%
109,933
+4.4%
0.00%0.0%
Q4 2016$1,846,000
-21.7%
105,322
+6.3%
0.00%0.0%
Q3 2016$2,357,000
+53.2%
99,111
+3.0%
0.00%0.0%
Q2 2016$1,539,000
-22.6%
96,199
+1.2%
0.00%0.0%
Q1 2016$1,988,000
-15.8%
95,082
+8.7%
0.00%0.0%
Q4 2015$2,361,000
-9.6%
87,500
-7.0%
0.00%
-50.0%
Q3 2015$2,613,000
+58.7%
94,069
+39.9%
0.00%
+100.0%
Q2 2015$1,647,000
+50.7%
67,245
+12.5%
0.00%0.0%
Q1 2015$1,093,000
+4.3%
59,795
+5.1%
0.00%0.0%
Q4 2014$1,048,000
+208.2%
56,871
+60.3%
0.00%
Q3 2014$340,000
+85.8%
35,481
+77.1%
0.00%
Q2 2014$183,000
+51.2%
20,038
+77.9%
0.00%
Q1 2014$121,00011,2640.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders